ClinicalTrials.gg
RecruitingNCT07878065Updated Oct 16, 2026

Artistic and Movement Activities to Reduce Anxiety in Children With Acute Lymphoblastic Leukemia.

A Phase 3 interventional study of Art and physical activity program. in Anxiety and Acute Leukemia, sponsored by Children's Cancer Hospital Egypt 57357. Recruiting at 1 site in Egypt. Open to participants aged 8 Years to 13 Years. Per ClinicalTrials.gov, last updated 2026-10-16.

Sponsored by Children's Cancer Hospital Egypt 57357 · Phase 3, Interventional, and Prevention

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled Jan 2026, registered Sep 2026).
  • Started Jan 2026; still recruiting 9 months later.
Updated Oct 16, 2026Newly registeredGo to Updates ↓
Phase
Phase 3
Study type
Interventional
Enrollment
76
Allocation
Randomized
Ages
8 Years to 13 Years
Sex
All
01

Study summary

The goal of this clinical trial is to evaluate whether a combined artistic and motor activity program can reduce anxiety in children aged 8-13 with acute lymphoblastic leukemia (ALL) undergoing chemotherapy at Children's Cancer Hospital Egypt 57357. The main questions it aims to answer are:

  • Does participation in the program reduce anxiety compared to standard care?
  • Does the program improve psychological well-being, social interaction, and coping during treatment? Researchers will compare an experimental group (receiving the artistic and motor program) with a control group (receiving standard care only) to see if the intervention lowers anxiety scores on the Spence Children's Anxiety Scale.

Participants will:

  • Be randomly assigned to either the experimental or control group.
  • Complete pre- and post-intervention anxiety assessments.

In the experimental group:

  • Attend 16 weekly sessions over 4 months.
  • Participate in art workshops (drawing, coloring, group activities).
  • Engage in motor activities (warm-up, progressive exercises, relaxation, light games, treadmill/cycling up to 5 minutes).

In the control group:

Will not be exposed to the program, with anxiety measured before and after the same period.

02

Conditions studied

  • Anxiety
  • Acute Leukemia

Browse trials for

Keywords

  • pediatric anxiety
  • Spence Children's Anxiety Scale (SCAS)
03

In context

Anxiety Disorders

5,063 studies on the registry are indexed under Anxiety Disorders; 1,408 are open to participants now.

This study's planned enrollment of 76 is close to the median of 80 across 4,339 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Children's Cancer Hospital Egypt 57357 is the lead sponsor of 21 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 13 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age from 8 to 13 years old as recorded in the hospital's official records.
  • Children who experience feelings of anxiety.
  • Medical fitness of the patient (confirmed through medical examination under the supervision of the specialist physician) before implementing the physical abilities program.
  • Being in the third stage of the treatment protocol.

Exclusion criteria

Exclusion Criteria:

  • Cases that are already under follow-up with the psychiatric clinic.
  • Cases that miss 4 sessions of the program.
  • Cases that do not suffer from anxiety.
05

Study design

Phase
Phase 3
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
76 participants (estimated)

Study arms

  • Experimental
    Experimental

    Participants will receive a structured program combining physical activity and art workshops. They will complete pre- and post-assessments.

    Behavioral: Art and physical activity program.

  • No intervention
    Control

    Participants will complete pre- and post-assessments but will not receive the art or physical activity program.

Interventions

  • BehavioralArt and physical activity program.

    Physical Activity Program: 16 sessions over 4 months, each lasting 20-30 minutes. Includes warm-up exercises, progressive muscle activities, relaxation techniques, and group games. From the second phase, children may use a treadmill or stationary bike for up to 5 minutes. Art Program: 16 weekly sessions over 4 months. Activities include drawing, coloring, and creative workshops to help children express emotions, reduce anxiety, and improve social interaction.

06

What researchers measure

Primary outcomes

  1. Spence Children's Anxiety Scale, Arabic translation by Dr. Abdel Aziz Mousa

    The Spence Scale measures 6 domains (6 subscales): * Panic and agoraphobia * Separation anxiety (fear of being away from mother) * Fear of physical injury * Social phobia * Obsessive-compulsive symptoms * Generalized/excessive anxiety Age range: Applied to children and adolescents aged 8-15 years. Structure: Contains 45 items, each with 4 response options. Response scoring: "Never" = 0 "Sometimes" = 1 "Often" = 2 "Always" = 3 Administration: The child either self-reports by marking the chosen option, or the examiner reads the items aloud and records the child's answers. Scoring: Raw scores are summed for each of the six domains according to the designated items. Raw scores are then converted into T-scores, adjusted for age and gender. Classification: 0-40 = Normal Above 40 = Elevated anxiety

    Time frame: Baseline (pre-assessment) and after 4 months (post-assessment)

07

Study locations

1 of 1 sites recruiting
  • Children's cancer hospital 57357
    Cairo, Cairo Governorate 11617, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 16, 2026
Show all 1 update
  1. Oct 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07878065
Lead sponsor
Children's Cancer Hospital Egypt 57357
Responsible party
Sponsor
First posted
Oct 16, 2026
Start date
Jan 21, 2026
Primary completion
Oct 24, 2026 (estimated)
Completion
Nov 24, 2026 (estimated)
Last update
Oct 16, 2026

Study contacts

Nancy Ashraf Abdellatif
Contact
nancy.ashraf@57357.com
+201141083507
Fawkya Khaled Abdelmoneim
principal investigator · Children's cancer hospital 57357

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion